This article is a literature review that emphasis the impact of testicular cancer on fertility and current management to prevent and treat infertility. Foreign literature has a lot of multicenter prospective longitudinal and retrospective studies of negative effects on fertility in men with teticular cancer. Testicular cancer has a negative impact on fertility because of its high incidence (7.52 cases per 100000 of the population) in young men with age between 15 and 35 years old. At the time they discover they have testicular cancer, many man have few or no sperm. In addition, all of the treatment for testicular cancer can directly or indirectly cause fetility problems. Sperm abnormatilies are frequent in men with testicular cancer. Patiens who underwent chemotherapy with bleomicin, doxorubicin, cisplatin or radiotherapy have a high risk to develop sperm aneuploidy. Genetic and psychological counseling should be done before choosing any treatment for testicular cancer. Sperm and embryo cryopreservation should be considered as early as possible before any treatement for testicular cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.